The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Ambi Even and Clear Facial Moisturizer
Homosalate 15%, Octisalate 5%, Octocrylene 3%, Avobenzone 3% · OCTISALATE 5 mg/mL; AVOBENZONE 3 mg/mL; HOMOSALATE 15 mg/mL; OCTOCRYLENE 3 mg/mL · Cream · Topical · 73453-112
NDC 73453-0112-01 · 1 TUBE in 1 BOX / 103 mL in 1 TUBE · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M020
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Homosalate 15%, Octisalate 5%, Octocrylene 3%, Avobenzone 3% (Cream)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| 73453-112 | OCTISALATE 5 mg/mL; AVOBENZONE 3 mg/mL; HOMOSALATE 15 mg/mL; OCTOCRYLENE 3 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| 73453-112 | OCTISALATE 3 mg/mL; AVOBENZONE 15 mg/mL; HOMOSALATE 5 mg/mL; OCTOCRYLENE 3 mg/mL | Jul 22, 2026 | Aug 19, 2026 |
| 73453-112 | AVOBENZONE 3 mg/mL; HOMOSALATE 15 mg/mL; OCTISALATE 5 mg/mL; OCTOCRYLENE 3 mg/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Ambi Even and Clear Facial Moisturizer — NDC 73453-0112-01," retrieved September 3, 2026, https://drugdashboards.com/drug/73453011201.
Free to cite with attribution — see how the data is put together.